0001567619-20-016270.txt : 20200901
0001567619-20-016270.hdr.sgml : 20200901
20200901214415
ACCESSION NUMBER: 0001567619-20-016270
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200831
FILED AS OF DATE: 20200901
DATE AS OF CHANGE: 20200901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PYOTT DAVID E I
CENTRAL INDEX KEY: 0001051578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 201155606
MAIL ADDRESS:
STREET 1: C/O ALLERGAN
STREET 2: 2525 DUPONT DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2020-08-31
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001051578
PYOTT DAVID E I
105 DIGITAL DRIVE
NOVATO
CA
94949
1
0
0
0
Common Stock
2020-08-31
4
P
0
11900
78.2151
A
29840
D
Common Stock
2020-08-31
4
P
0
900
78.8393
A
30740
D
The price in column 4 is the weighted average price. The actual purchase price paid ranged from $77.78 to $78.76. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.
The price in column 4 is the weighted average price. The actual purchase price paid ranged from $78.78 to $78.91. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2020-09-01